Global Vitamin B12 Series API Market Growth 2024-2030

Global Vitamin B12 Series API Market Growth 2024-2030

Vitamin B12 series APIs are a group of pharmaceutical grade cobalt compounds, namely cobalamin, including cyanocobalamin, adenosylcobalamin, hydroxocobalamin and methylcobalamin. Vitamin B12 can be divided into pharmaceutical grade, food grade and feed grade. Vitamin B12 derivatives are generally pharmaceutical grade and used in medicines, including adenosylcobalamin, hydroxocobalamin and methylcobalamin.

The global Vitamin B12 Series API market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Vitamin B12 Series API Industry Forecast” looks at past sales and reviews total world Vitamin B12 Series API sales in 2023, providing a comprehensive analysis by region and market sector of projected Vitamin B12 Series API sales for 2024 through 2030. With Vitamin B12 Series API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vitamin B12 Series API industry.

This Insight Report provides a comprehensive analysis of the global Vitamin B12 Series API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vitamin B12 Series API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vitamin B12 Series API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vitamin B12 Series API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vitamin B12 Series API.

United States market for Vitamin B12 Series API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Vitamin B12 Series API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Vitamin B12 Series API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Vitamin B12 Series API players cover EUROAPI, Eisai Co., Ltd, HTBA, Cspc Holdings Company, Ningxia Kingvit Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Vitamin B12 Series API market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Cyanocobalamin
Methylcobalamin
Adenosylcobalamin
Hydroxocobalamin

Segmentation by Application:
Oral Formulation
Injectable Formulation
Sprays

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
EUROAPI
Eisai Co., Ltd
HTBA
Cspc Holdings Company
Ningxia Kingvit Pharmaceutical
Yufeng Industry Group
North China Pharmaceutical Company

Key Questions Addressed in this Report

What is the 10-year outlook for the global Vitamin B12 Series API market?

What factors are driving Vitamin B12 Series API market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Vitamin B12 Series API market opportunities vary by end market size?

How does Vitamin B12 Series API break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.